Dr
Jennifer
Carlisle

Experience

Jennifer graduated in 2009 from the University of Bath with a First Class MChem honours degree in Chemistry for Drug Discovery with Industrial Training. She then completed a PhD in Organic Chemistry at the University of Bath, focusing on the asymmetric synthesis of highly substituted lactones for use in natural product synthesis. She joined HGF in May 2016.

Jennifer’s undergraduate degree provided her with a broad understanding of medicinal chemistry, including some aspects of biochemistry and pharmacology. She completed an industrial placement at AstraZeneca where she worked as a Synthetic Organic Chemist in the lead optimisation stage of drug discovery. Her PhD research involved the development of novel methodology for the asymmetric synthesis of building blocks for use in natural product synthesis. This work resulted in three publications and was presented at two international conferences.

After her PhD, Jennifer spent two years working in R&D for a specialist diabetes diagnostics company. This project focused on the design and synthesis of novel boronic acid fluorophore conjugates for use in an HbA1c assay.

Before joining HGF, Jennifer was the Industry Manager for the NIHR Diagnostic Evidence Cooperative based at Imperial College London. During this time, she was responsible for developing a portfolio of industry collaborative clinical studies for Point-of-Care in vitro diagnostic device evaluation.